Interrogation of SrtA active site loop forming open/close lid conformations through extensive MD simulations for understanding binding selectivity of SrtA inhibitors.

Chandrabose Selvaraj, Gurudeeban Selvaraj, Randa Mohamed Ismail, Rajendran Vijayakumar, Alaa Baazeem, Dong-Qing Wei, Sanjeev Kumar Singh
Author Information
  1. Chandrabose Selvaraj: Department of Bioinformatics, Computer Aided Drug Design and Molecular Modelling Lab, Science Block, Alagappa University, Karaikudi, Tamil Nadu, India.
  2. Gurudeeban Selvaraj: Centre for Research in Molecular Modelling, Concordia University, 5618 Montreal, Quebec, Canada.
  3. Randa Mohamed Ismail: Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia.
  4. Rajendran Vijayakumar: Department of Biology, College of Science in Zulfi, Majmaah University, Majmaah 11952, Saudi Arabia.
  5. Alaa Baazeem: Department of Biology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
  6. Dong-Qing Wei: Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
  7. Sanjeev Kumar Singh: Department of Bioinformatics, Computer Aided Drug Design and Molecular Modelling Lab, Science Block, Alagappa University, Karaikudi, Tamil Nadu, India.

Abstract

is a gram positive, deadly spore forming bacteria causing anthrax and these bacteria having the complex mechanism in the cell wall envelope, which can adopt the changes in environmental conditions. In this, the membrane bound cell wall proteins are said to progressive drug target for the inhibition of . Among the cell wall proteins, the SrtA is one of the important mechanistic protein, which mediate the ligation with LPXTG motif by forming the amide bonds. The SrtA plays the vital role in cell signalling, cell wall formation, and biofilm formations. Inhibition of SrtA leads to rupture of the cell wall and biofilm formation, and that leads to inhibition of and thus, SrtA is core important enzyme to study the inhibition mechanism. In this study, we have examined 28 compounds, which have the inhibitory activity against the SrtA for developing the 3D-QSAR and also, compounds binding selectivity with both open and closed SrtA conformations, obtained from 100 ns of MD simulations. The binding site loop deviate in forming the open and closed gate mechanism is investigated to understand the inhibitory profile of reported compounds, and results show the closed state active site conformations are required for ligand binding specificity. Overall, the present study may offer an opportunity for better understanding of the mechanism of action and can be aided to further designing of a novel and highly potent SrtA inhibitors.

Keywords

References

  1. Curr Comput Aided Drug Des. 2017;13(1):75-83 [PMID: 27897106]
  2. Molecules. 2018 May 16;23(5): [PMID: 29772697]
  3. Comb Chem High Throughput Screen. 2013 May;16(4):249-73 [PMID: 23305140]
  4. J Mol Recognit. 2014 Dec;27(12):696-706 [PMID: 25319617]
  5. Molecules. 2019 Mar 07;24(5): [PMID: 30866507]
  6. Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20239-44 [PMID: 19073921]
  7. J Mol Recognit. 2014 Jul;27(7):429-37 [PMID: 24895275]
  8. J Comput Chem. 2005 Dec;26(16):1701-18 [PMID: 16211538]
  9. Biochemistry. 2005 Aug 23;44(33):11188-200 [PMID: 16101303]
  10. Front Chem. 2021 Jan 13;8:595273 [PMID: 33585398]
  11. Cold Spring Harb Perspect Biol. 2010 May;2(5):a000414 [PMID: 20452953]
  12. Methods Mol Biol. 2018;1800:141-169 [PMID: 29934891]
  13. J Comput Aided Mol Des. 2013 Mar;27(3):221-34 [PMID: 23579614]
  14. Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):573-83 [PMID: 25572737]
  15. Microbiol Mol Biol Rev. 1999 Mar;63(1):174-229 [PMID: 10066836]
  16. Bioinformatics. 2013 Apr 1;29(7):845-54 [PMID: 23407358]
  17. Methods Mol Biol. 2012;914:271-84 [PMID: 22976034]
  18. Exp Suppl. 2012;101:381-411 [PMID: 22945576]
  19. Microbiol Spectr. 2016 Aug;4(4): [PMID: 27726794]
  20. J Biol Chem. 2015 Oct 16;290(42):25461-74 [PMID: 26324714]
  21. J Chem Inf Model. 2015 Jul 27;55(7):1316-22 [PMID: 26099013]
  22. Curr Comput Aided Drug Des. 2018;14(4):284-291 [PMID: 29701159]
  23. Bioorg Med Chem. 2009 Oct 15;17(20):7174-85 [PMID: 19781950]
  24. J Mol Graph Model. 2008 Jun;26(8):1315-26 [PMID: 18328754]
  25. SAR QSAR Environ Res. 2013;24(12):1025-40 [PMID: 23987088]
  26. Microbiol Mol Biol Rev. 2006 Mar;70(1):192-221 [PMID: 16524923]
  27. J Biol Chem. 2007 Mar 2;282(9):6571-81 [PMID: 17200112]
  28. Infect Disord Drug Targets. 2019;19(2):145-166 [PMID: 30324898]
  29. J Biol Chem. 2010 Jul 23;285(30):23433-43 [PMID: 20489200]
  30. J Biomol Struct Dyn. 2013;31(6):561-71 [PMID: 22881193]
  31. Curr Top Med Chem. 2018;18(29):2462-2480 [PMID: 30499405]
  32. Med Chem. 2008 Jul;4(4):313-21 [PMID: 18673142]
  33. SAR QSAR Environ Res. 2013;24(7):581-95 [PMID: 23521430]
  34. Annu Rev Microbiol. 2013;67:313-36 [PMID: 24024634]
  35. J Enzyme Inhib Med Chem. 2012 Jun;27(3):339-47 [PMID: 21699459]
  36. Glycobiology. 2021 Apr 01;: [PMID: 33822042]
  37. IEEE/ACM Trans Comput Biol Bioinform. 2020 Dec 11;PP: [PMID: 33306471]
  38. J Infect Dis. 2007 Jan 15;195(2):163-4 [PMID: 17191158]
  39. Adv Protein Chem Struct Biol. 2017;109:223-264 [PMID: 28683919]
  40. J Mol Recognit. 2012 Oct;25(10):504-12 [PMID: 22996593]
  41. Future Microbiol. 2012 Feb;7(2):227-39 [PMID: 22324992]
  42. Mol Microbiol. 2011 Dec;82(5):1044-59 [PMID: 22026821]
  43. J Biomol Struct Dyn. 2014;32(8):1333-49 [PMID: 23869520]
  44. J Chem Inf Model. 2009 Feb;49(2):437-43 [PMID: 19434844]
  45. Eur J Med Chem. 2006 Nov;41(11):1310-9 [PMID: 16890327]
  46. J Chem Inf Model. 2010 May 24;50(5):822-39 [PMID: 20423098]
  47. Food Chem Toxicol. 2018 Feb;112:495-506 [PMID: 28843597]
  48. J Chem Theory Comput. 2020 Apr 14;16(4):2460-2473 [PMID: 32207974]
  49. Microbes Environ. 2015;30(2):123-5 [PMID: 26094633]
  50. J Clin Pathol. 2003 Mar;56(3):182-7 [PMID: 12610093]
  51. Mol Biosyst. 2015 Jan;11(1):178-89 [PMID: 25335799]
  52. J Mol Graph Model. 2002 Jan;20(4):269-76 [PMID: 11858635]
  53. J Recept Signal Transduct Res. 2014 Oct;34(5):361-71 [PMID: 24694004]
  54. J Chem Inf Model. 2010 Apr 26;50(4):534-46 [PMID: 20373803]

Word Cloud

Created with Highcharts 10.0.0SrtAcellwallformingmechanismbindinginhibitionstudycompoundsclosedconformationssitebacteriacanproteinsimportantformationbiofilmleadsinhibitoryselectivityopenMDsimulationsloopactiveunderstandinginhibitorsgrampositivedeadlysporecausinganthraxcomplexenvelopeadoptchangesenvironmentalconditionsmembraneboundsaidprogressivedrugtargetAmongonemechanisticproteinmediateligationLPXTGmotifamidebondsplaysvitalrolesignallingformationsInhibitionrupturethuscoreenzymeexamined28activitydeveloping3D-QSARalsoobtained100nsdeviategateinvestigatedunderstandprofilereportedresultsshowstaterequiredligandspecificityOverallpresentmayofferopportunitybetteractionaideddesigningnovelhighlypotentInterrogationopen/closelidextensiveBacillusanthracisCelladhesionMoleculardynamicsPharmacophoremodellingQSARSortase

Similar Articles

Cited By